Results 41 to 50 of about 13,203 (228)

Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders

open access: yesFrontiers in Neurology, 2020
The loss of the senses of smell (anosmia) and taste (ageusia) are rather common disorders, affecting up to 20% of the adult population. Yet, this condition has not received the attention it deserves, most probably because per se such a disorder is not ...
Heike Rebholz   +9 more
doaj   +1 more source

Functional Covariance Connectivity of Gray and White Matter in Olfactory-Related Brain Regions in Parkinson’s Disease

open access: yesFrontiers in Neuroscience, 2022
Before the onset of motor symptoms, Parkinson’s disease (PD) involves dysfunction of the anterior olfactory nucleus and olfactory bulb, causing olfactory disturbance, commonly resulting in hyposmia in the early stages of PD.
Yiqing Wang   +11 more
doaj   +1 more source

Inflammatory Signatures Beyond Th1/Th2 Endotypes Provide Insights Into Postoperative Recurrence in Chronic Rhinosinusitis

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) represents a spectrum of inflammatory endotypes, driven by distinct T helper (Th) immune responses. The high rate of recurrent disease despite appropriate medical and surgical interventions highlights the need for improved characterization beyond the traditional type 2 and non‐type 2 phenotypes to better
Liyona Kampel   +9 more
wiley   +1 more source

Evaluation of olfactory bulb volume in patients with diabetic olfactopathy and comparison with healthy individuals

open access: yesB-ENT, 2021
Objective: Diabetic olfactopathy is defined as olfactory dysfunction in patients with diabetic neuropathy. In this study, we evaluated the olfactory bulb volume (OBV) using magnetic resonance imaging in patients with diabetic olfactopathy and compared ...
Defne Gürbüz   +3 more
doaj   +2 more sources

Clinical Longitudinal Evaluation After Regimen Stop (CLEAR) of Dupilumab in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Long‐term management strategies for severe chronic rhinosinusitis with nasal polyps (CRSwNP) increasingly include biologic therapy targeting Type 2 inflammation. However, data on outcomes after complete discontinuation of dupilumab following sustained disease control are scarce.
Patrick Huber   +7 more
wiley   +1 more source

UPSIT subitems may predict motor progression in Parkinson’s disease

open access: yesFrontiers in Neurology, 2023
BackgroundThe relationship between hyposmia and motor progression is controversial in Parkinson’s disease (PD). The aim of this study was to investigate whether preserved identification of Chinese-validated University of Pennsylvania Smell Identification
Yu-Hsuan Lin   +6 more
doaj   +1 more source

Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 [PDF]

open access: yesThe Lancet Infectious Diseases, 2020
[No abstract available]
Bénézit, François   +35 more
openaire   +3 more sources

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis

open access: yesWorld Journal of Otorhinolaryngology-Head and Neck Surgery, 2020
Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant
Daniel B. Spielman   +2 more
doaj   +1 more source

Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms

open access: yesFrontiers in Neuroscience, 2023
Purpose of reviewTo provide a detailed overview of the assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms.Recent findingsCOVID-19-related olfactory dysfunction can have a ...
Lavandan Jegatheeswaran   +10 more
doaj   +1 more source

Hyposmia impending neurodegeneration in rapid eye movement sleep behavior disorder [PDF]

open access: yes, 2022
Background- Approximately 50% to 80% of people with isolated rapid eye movement (REM) sleep behavior disorder (RBD) will likely be diagnosed with an overt synucleinopathy within their lifetimes.
Mohankumar, K. C.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy